Related Experiment Video
Updated: Jul 12, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic heterogeneity of left-ventricular noncompaction cardiomyopathy
Ewa Moric-Janiszewska1, Grazyna Markiewicz-Łoskot
1Department of Biochemistry, Medical University of Silesia, Sosnowiec, Poland.
Insights
Isolated noncompaction of the ventricular myocardium (INVM), or spongy myocardium, is a rare heart condition affecting systolic function. Genetic factors play a significant role, with mutations in several genes linked to its development and varying clinical presentations.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Isolated noncompaction of the ventricular myocardium (INVM), also known as spongy myocardium, is a rare cardiomyopathy.
- It presents in neonatal, childhood, and adult forms, commonly involving systolic dysfunction and deep ventricular trabeculations.
- While often sporadic, INVM can stem from chromosomal abnormalities or have familial incidence.
Purpose of the Study:
- To elucidate the genetic underpinnings of Isolated noncompaction of the ventricular myocardium.
- To review known genotype-phenotype correlations associated with this cardiomyopathy.
- To provide a comprehensive overview of the genetic background of INVM.
Main Methods:
- Literature review of genetic factors and genotype-phenotype correlations in Isolated noncompaction of the ventricular myocardium.
- Analysis of reported mutations in genes associated with INVM.
- Synthesis of information on familial and sporadic forms of the disease.
Main Results:
- Identified key mutated genes implicated in INVM, including G4.5 (tafazzin), DTNA, FKBP-12, lamin A/C, and Cypher/ZASP.
- Highlighted that the majority of adult INVM cases follow an autosomal dominant inheritance pattern.
- Noted associations between INVM genotypes and phenotypes such as Becker muscular dystrophy, Emery-Dreifuss muscular dystrophy, and Barth syndrome.
Conclusions:
- Genetic mutations are central to the pathogenesis of Isolated noncompaction of the ventricular myocardium.
- Understanding these genetic factors and their associated phenotypes is crucial for diagnosis and management.
- Further research into the genetic landscape of INVM can improve diagnostic accuracy and therapeutic strategies.
Abstract:
Isolated noncompaction of the ventricular myocardium (INVM) sometimes referred to as spongy myocardium is a rare, congenital and also acquired cardiomyopathy. It appears to divide the presentation into neonatal, childhood and adult forms of which spongy myocardium and systolic dysfunction is the commonality. The disorder is characterized by a left ventricular hypertrophy with deep trabeculations, and with diminished systolic function, with or without associated left ventricular dilation. In half or more of the cases, the right ventricle is also affected. The sporadic type, however, in some patients, may be due to chromosomal abnormalities and the occurrence of familial incidence. Isolated noncompaction of the left ventricular myocardium in the majority of adult patients is an autosomal dominant disorder. The familial and X-linked disorders have been described by various authors. We here describe the genetic background of this disorder: some of the most mutated genes that are responsible for the disease are (G4.5 (tafazzin gene): alpha-dystrobrevin gene (DTNA); FKBP-12 gene; lamin A/C gene; Cypher/ZASP (LIM, LDB3) gene); and some genotype-phenotype correlations (Becker muscular dystrophy, Emery-Dreifuss muscular dystrophy or Barth syndrome) based on the literature review.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...

